Related Experiment Video
Updated: Jun 29, 2025

Advanced Glycation End-Products Sensitize Human Sensory-Like Neuron Cells to Capsaicin-Induced Calcium Influx
Published on: May 2, 2025
Modulation of TRPV1 on Odontoblast-like Cells Using Capsazepine-Loaded Nanogels
Lilia Jadith Bernal-Cepeda1, Ronald Andrés Jiménez2, Myriam L Velandia-Romero3
1IBAPO Group, School of Dentistry, Universidad Nacional de Colombia, Bogota 111321, Colombia.
Abstract:
The modulation of TRPV1 emerges as a promising strategy for dental pain management. This study aimed to assess TRPV1 modulation in a human odontoblast-like cell model using Capsazepine (CZP) loaded in a nanogel delivery system. Gelatin nanogels, synthesized via the emulsification-gelation technique, were characterized and loaded with the TRPV1 antagonist, CZP. HPLC determined a remarkable 67.5 ± 0.04% CZP loading efficiency, with 71.7% of nanogels falling within the 300-950 nm size range, as evidenced by light microscopy. Moreover, CZP-loaded nanogels had a low cytotoxicity. An FTIR analysis showed no adverse chemical interactions, ensuring stability and active release. When examining biological responses, TRPV1 expression and channel activity were assessed in odontoblast-like cells. On the fifth day post-treatment, cells treated with CZP-loaded nanogels exhibited an increased TRPV1 expression and a reduction in calcium fluxes after agonist stimulus (F/F0 ratio 1.18 ± 0.18), resembling the response in free CZP-treated cells (1.28 ± 0.15). A two-way analysis of variance and the Tukey's test were used to determine statistical significance (p < 0.05). This delivery system, proven to be economical and straightforward, holds promise for dental pain management and potential local use. Local administration minimizes systemic adverse effects, making it a practical solution for releasing molecules in the oral cavity.
Insights
This study developed a nanogel delivery system for Capsazepine (CZP) to manage dental pain by modulating TRPV1. The system effectively delivered CZP, reducing calcium fluxes in dental cells and showing promise for local pain management.
Area of Science:
- Biomaterials Science
- Pain Management
- Cell Biology
Background:
- Transient Receptor Potential Vanilloid 1 (TRPV1) modulation is a key strategy for managing dental pain.
- Developing effective delivery systems is crucial for localized therapeutic action and minimizing side effects.
Purpose of the Study:
- To assess TRPV1 modulation in a human odontoblast-like cell model using Capsazepine (CZP) delivered via a nanogel system.
- To characterize the nanogel properties and evaluate its efficacy in modulating TRPV1 activity.
Main Methods:
- Gelatin nanogels loaded with CZP were synthesized using emulsification-gelation.
- Nanogel characterization included HPLC for loading efficiency and light microscopy for size analysis.
- TRPV1 expression and calcium fluxes were assessed in odontoblast-like cells post-treatment.
Main Results:
- High CZP loading efficiency (67.5%) and optimal nanogel size (300-950 nm) were achieved.
- CZP-loaded nanogels demonstrated low cytotoxicity and no adverse chemical interactions.
- Cells treated with CZP-loaded nanogels showed increased TRPV1 expression and reduced calcium influx post-stimulation.
Conclusions:
- The developed nanogel system is an economical and effective method for delivering CZP to modulate TRPV1.
- This system holds significant promise for localized dental pain management with reduced systemic adverse effects.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Mechanically-gated Ion Channels

